Co-Diagnostics, Inc
Price
FilingsNewest: 8-K, Shareholder voteOct 2 →InsidersNo open-market buys or sales.→HoldersArmistice Capital 4.8%Jane Street 1.8%Vanguard 1.2%→Financing →PeersClosest companies: AIDX, PHIO, INBS→
From the filings
Figures
- Revenue
- $721,387last 12 months
- Net income
- −$47.2Mlast 12 months
- Operating cash flow
- −$28.2Mlast 12 months
- Cash and equivalents
- $3.6Mat the last balance sheet
- Shares outstanding
- 4.9M shareson issue